eISSN: 3079-3912 / ISSN: 3079-3904
Register
Login
European Journal of Medical Practitioners
2023, Volume 1, Issue 2 : 1-8
Research Article
The Role of Lifestyle Modification in Type 2 Diabetes Management
 ,
 ,
 ,
1
Department of Endocrinology, Global Health Research Institute, New York, USA
2
Department of Public Health and Preventive Medicine, Western Medical University, California, USA
3
Department of Nutrition Sciences, International Institute of Health Sciences, London, UK
4
Department of Clinical Research and Metabolic Disorders, Middle East Medical Research Center, Dubai, UAE
Abstract

Background

Type 2 Diabetes Mellitus (T2DM) is a major global public health challenge characterized by chronic hyperglycemia resulting from insulin resistance and impaired insulin secretion. Lifestyle factors such as poor dietary habits, physical inactivity, obesity, smoking, and chronic stress significantly contribute to disease development and progression. Lifestyle modification has emerged as a cornerstone in diabetes management, offering substantial benefits in glycemic control and prevention of complications.

Objective

This study evaluates the impact of lifestyle modification interventions, including dietary changes, physical activity, weight management, stress reduction, and smoking cessation, on the management of Type 2 Diabetes Mellitus.

Methods

A retrospective review and comparative analysis were conducted using clinical data from 500 patients diagnosed with T2DM. Patients were divided into two groups: those receiving standard medical therapy alone and those receiving standard therapy combined with structured lifestyle interventions. Outcomes were assessed over a 12-month period.

Results

Patients participating in lifestyle modification programs demonstrated significantly improved glycemic control, reduced HbA1c levels, weight reduction, improved lipid profiles, and lower cardiovascular risk compared with the control group.

Conclusion

Lifestyle modification plays a critical role in Type 2 Diabetes management and should be integrated into routine clinical practice as a primary therapeutic strategy alongside pharmacological treatment.

 

Keywords
License
Copyright (c) European Journal of Medical Practitioners
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Eur. J. Med. Pract. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Impact of Artificial Intelligence on Clinical Decision-Making in Primary Care
1-6
Determinants of Healthcare Accessibility in Developing Regions: A Cross-Sectional Analysis of Socioeconomic, Geographic, and System-Level Factors
1-8
Predictors of Heart Failure Progression in Elderly Patients
1-9
Assessment of Medication Adherence in Patients with Chronic Diseases
1-7
European Journal of Medical Practitioners
support@ejmponline.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©European Journal of Medical Practitioners. All rights reserved.
|
|
|